Ocular toxicology of marijuana: an update

References

• Green K. Marihuana and the eye—a review. J. Toxicol.—Cut. Ocular Toxicol. 1982; 1: 3
   Web of Science ®Google Scholar
• The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects, S. Agurell, W. L. Dewey, R. E. Willette. Academic Press, New York 1984
   Google Scholar
• Marihuana in Science and Medicine, G. G. Nahas. Raven Press, New York 1984
   Google Scholar
• Adverse Health and Behavioral Consequences of Cannabis Use, K. O. Fehr, H. Kalant. Addictive Research Foundation, TorontoCanada 1983
   Google Scholar
• Pharmacol. Rev. 1986; 38: 21–178
   PubMed Web of Science ®Google Scholar
• Wood G. B., Bache F. The Dispensatory of the United States of America. J. B. Lippincott, Philadelphia 1868
   Google Scholar
• Nahas G. G. Marihuana—Deceptive Weed. Raven Press, New York 1973
   Google Scholar
• Snyder S. The Uses of Marihuana. Oxford University Press, London 1971
   Google Scholar
• Waller C. W., Nair R. S., McAllister A. F., Urbanek B., Turner C. E. Marihuana: An Annotated Bibliography, Volume II. MacMillan, New York 1982
   Google Scholar
• Hollister L. E. Health aspects of cannabis. Pharmacol. Rev. 1986; 38: 1
   PubMed Web of Science ®Google Scholar
• Allen T. Tetrahydrocannabinol and chemotherapy. N. Engl. J. Med. 1976; 294: 168
   PubMedGoogle Scholar
• Agurell S., Halldin M., Lindgren J.-E., Ohlsson A., Widman M., Gillespie H., Hollister L. Pharmacokinetics and metabolism of Δ1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol. Rev. 1986; 38: 21
   PubMed Web of Science ®Google Scholar
• Nahas G. G. Toxicology and pharmacology. Marihuana in Science and Medicine, G. G. Nahas. Raven Press, New York 1984
   Google Scholar
• Nahas G. G. The medical use of cannabis. Marihuana in Science and Medicine, G. G. Nahas. Raven Press, New York 1984
   Google Scholar
• Lemberger L., Crabtree R. E., Rowe H. M. 11-hydroxy-Δ9-tetrahydrocannabinol: Pharmacology, disposition, and metabolism of a major metabolite of marihuana in man. Science 1972; 177: 62
   PubMed Web of Science ®Google Scholar
• Dewey W. L. Cannabinoid pharmacology. Pharmacol. Rev. 1986; 38: 15
   Google Scholar
• Klonoff H. Acute psychological effects of marihuana in man, including acute cognitive, psychomotor, and perceptual effects in driving. Adverse Health and Behavioral Consequences of Cannabis Use, K. O. Fehr, H. Kalant. Addictive Research Foundation, Toronto 1983
   Google Scholar
• Munson A. E., Fehr K. O. Immunological effects of cannabis. Adverse Health and Behavioral Consequences of Cannabis Use, K. O. Fehr, H. Kalant. Addictive Research Foundation, Toronto 1983
   Google Scholar
• Bloch E. Effects of marihuana and cannabinoids in reproduction, endocrine function, development, and chromosomes. Adverse Health and Behavioral Consequences of Cannabis Use, K. O. Fehr, H. Kalant. Addictive Research Foundation, Toronto 1983
   Google Scholar
• Rosenkrantz H. Cannabis, marihuana, and cannabinoid toxicological manifestations in man and animals. Adverse Health and Behavioral Consequences of Cannabis Use, K. O. Fehr, H. Kalant. Addictive Research Foundation, Toronto 1983
   Google Scholar
• Martin B. R. Cellular effects of cannabinoids. Pharmacol. Rev. 1986; 38: 45
   PubMed Web of Science ®Google Scholar
• McLane N. J., Carroll D. M. Ocular manifestations of drug abuse. Surv. Ophthalmol. 1986; 30: 298
   PubMed Web of Science ®Google Scholar
• Dawson W. W., Jiminez-Antillon C. F., Perez J. M., Zeskind J. A. Marihuana and vision after ten years' use in Costa Rica. Invest. Ophthalmol. 1977; 16: 689
   Google Scholar
• Merritt J. C., Cook C. E., Davis K. H. Orthostatic hypotension after Δ9-tetrahydrocannabinol marihuana inhalation. Ophthal. Res. 1982; 14: 124
   PubMed Web of Science ®Google Scholar
• Tiedeman J. S., Shields M. B., Weber P. A., Crow J. N., Corletto D. M., Harris W. A., Howes J. P. Effect of synthetic cannabinoids on elevated intraocular pressure. Ophthalmology 1981; 88: 270
   PubMed Web of Science ®Google Scholar
• Green K. Marijuana effects on intraocular pressure. Glaucoma: Applied Pharmacology in Medical Treatment, S. M. Drance, A. H. Neufeld. Grune & Stratton, Orlando 1984
   Google Scholar
• Crawford W. J., Merritt J. C. Effects of tetrahydrocannabinol on arterial and intraocular hypertension. Int. J. Clin. Pharmacol. Biopharm. 1979; 17: 191
   PubMedGoogle Scholar
• Cooler P., Gregg J. M. The effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans. Therapeutic Potential of Marihuana, S. Cohen, R. C. Stillman. Plenum Press, New York
   Google Scholar
• Merritt J. C., McKinnon S. M., Armstrong J. R., Katern G., Reid L. A. Oral Δ9-tetrahydrocannabinol in hypertensive glaucomas. Ann. Ophthalmol. 1980; 12: 947
   Web of Science ®Google Scholar
• Perez-Reyes M., Wagner D., Wall M. E., Davis K. H. Intravenous administration of cannabinoids on intraocular pressure. The Pharmacology of Marihuana, M. C. Braude, S. Szara. Raven Press, New York 1976
   Google Scholar
• Hepler R. S., Frank I. M., Petrus R. Ocular effects of marijuana smoking. The Pharmacology of Marihuana, M. C. Braude, S. Szara. Raven Press, New York 1976
   Google Scholar
• Hepler R. S., Petrus R. Experiences with administration of marihuana to glaucoma patients. The Therapeutic Potential of Marihuana, S. Cohen, R. C. Stillman. Plenum Press, New York 1976
   Google Scholar
• Green K., Bowman K. A. Effect of marihuana derivatives on intraocular pressure. The Pharmacology of Marihuana, M. C. Braude, S. Szara. Raven Press, New York 1976
   Google Scholar
• El-Sohly M. A., Harland E., Murphy J. C., Wirth P., Waller C. W. Cannabinoids in glaucoma: A primary screening procedure. J. Clin. Pharmacol. 1981; 21: 472S
   PubMed Web of Science ®Google Scholar
• Green K., Symonds C. M., Oliver N. W., Elijah R. D. Intraocular pressure following systemic administration of cannabinoids. Curr. Eye Res. 1982; 2: 247–83
   PubMed Web of Science ®Google Scholar
• El-Sohly M. A., Harland E. C., Benigni D. A., Waller C. W. Cannabinoids in glaucoma II; The effect of different cannabinoids on intraocular pressure of the rabbit. Curr. Eye Res. 1984; 3: 841
   PubMed Web of Science ®Google Scholar
• Waller C. W., Benigni D. A., Harland E. C., Bedford J. A., Murphy J. C., El-Sohly M. A. Cannabinoid in glaucoma III: The effects of different cannabinoids on intraocular pressure in the monkey. The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects, S. Agurell, W. L. Dewey, R. E. Willette. Academic Press, New York 1984
   Google Scholar
• Howes J. F. Antiglaucoma effects of topically and orally administered cannabinoids. The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects, S. Agurell, W. L. Dewey, R. E. Willette. Academic Press, New York 1984
   Google Scholar
• Green K., Sobel R. E., Fineberg E., Wynn H. R., Bowman K. A. Subchronic ocular and systemic toxicity of topically applied Δ9-tetrahydrocannabinol. Ann. Ophthalmol. 1981; 13: 1219
   PubMed Web of Science ®Google Scholar
• Merritt J. C., Whitaker R., Page C. J., Peace J. H., Grinson R. C., Olsen J. C., Peiffer R. L., Davanzo R. Topical Δ8-tetrahydrocannabinol as a potential glaucoma agent. Glaucoma 1982; 4: 253
   Google Scholar
• Merritt J. C., Peiffer R. L., McKinnon S. M., Stapleton S. S., Goodwin T., Risco J. M. Topical Δ9-tetrahydrocannabinol on intraocular pressure in dogs. Glaucoma 1981; 3: 13
   Google Scholar
• Mechoulam R., Lander H., Srebnik M., Zamir I., Breuer A., Shalita B., Dikstein S., Carlini E. A., Leite J. R., Edery H., Porath G. Recent advances in the use of cannabinoids as therapeutic agents. The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects, S. Agurell, W. L. Dewey, R. E. Willette. Academic Press, New York 1984
   Google Scholar
• Colasanti B. K., Powell S. R., Craig C. R. Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta-9-tetrahydrocannabinol or cannabichromene. Exp. Eye Res. 1984; 38: 63
   PubMed Web of Science ®Google Scholar
• Colasanti B. K., Craig C. R., Allara R. D. Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol. Exp. Eye Res. 1984; 39: 251
   PubMed Web of Science ®Google Scholar
• Colasanti B. K., Brown R. E., Craig C. R. Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol. Gen. Pharmacol. 1984; 15: 479
   PubMedGoogle Scholar
• Colasanti B. K., Powell S. R. Factors involved in the intraocular pressure lowering effect of Δ9-tetrahydrocannabinol (Δ9-THC) in the cat. Invest. Ophthalmol. Vis. Sci. 1985; 26(suppl.)232
   Google Scholar
• Colasanti B. K., Gong H. Cannabinoid effects on aqueous humor dynamics in the cat. Invest. Ophthalmol. Vis. Sci. 1987; 28(suppl.)12
   Google Scholar
• Colasanti B. K., Powell S. R. Effect of Δ9-tetrahydrocannabinol on intraocular pressure after removal of autonomic input. J. Ocular Pharmacol. 1985; 1: 47
   PubMedGoogle Scholar
• Chiang C.-W. N., Barrett B. G., Brine D. Systemic absorption of Δ9-tetrahydrocannabinol after ophthalmic administration to the rabbit. J. Pharm. Sci. 1983; 72: 136
   PubMed Web of Science ®Google Scholar
• Galanter M., Wyatt R. J., Lemberger L., Weingartner H., Vaughan T. B., Roth W. T. Effects on humans of Δ9-tetrahydrocannabinol administered by smoking. Science 1972; 176: 934
   PubMed Web of Science ®Google Scholar
• Liu J. H. K., Dacus A. C. Central nervous system and peripheral mechanism in ocular hypotensive effect of cannabinoids. Arch. Ophthalmol. 1987; 105: 245
   PubMed Web of Science ®Google Scholar
• Liu J. H. K., Neufeld A. H. Study of central regulation of intraocular pressure using ventriculocisternal perfusion. Invest. Ophthalmol. Vis. Sci. 1985; 26: 136
   PubMed Web of Science ®Google Scholar
• Gawienowski A. M., Chatterjee D., Anderson P. J., Epstein D. L., Grant W. M. Effect of Δ9-tetrahydrocannabinol on monoamine oxidase activity in bovine eye tissues, in vitro. Invest. Ophthal. Vis. Sci. 1982; 22: 482
   PubMed Web of Science ®Google Scholar
• Merritt J. C., Olsen J. L., Armstrong J. R., McKinnon S. M. Topical Δ9-tetrahydrocannabinol in humans. J. Pharm. Pharmacol. 1981; 33: 40
   PubMed Web of Science ®Google Scholar
• Merritt J. C., Perry D. D., Russell D. N., Jones B. F. Topical Δ9-tetrahydrocannabinol and aqueous dynamics in glaucoma. J. Clin. Pharmacol. 1981; 21: 467S
   PubMed Web of Science ®Google Scholar
• Green K., Roth M. Ocular effects of topical administration of Δ9-tetrahydrocannabinol in man. Arch. Ophthalmol. 1982; 100: 265
   PubMed Web of Science ®Google Scholar
• Jay W. M., Green K. Multiple-drop study of topically applied 1% Δ9-tetrahydrocannabinol in human eyes. Arch. Ophthalmol. 1983; 101: 591
   PubMed Web of Science ®Google Scholar
• Deutsch H. M., Green K., Zalkow L. H. Isolation of ocular hypotensive compounds from Cannabis sativa. J. Clin. Pharmacol. 1981; 21: 479S
   PubMed Web of Science ®Google Scholar
• Green K., Zalkow L. H., Deutsch H. M., Yablonski M. E., Oliver N., Symonds C. M., Elijah R. D. Ocular and systemic responses to water-soluble material derived from Cannabis sativa (marihuana). Curr. Eye Res. 1981; 1: 65
   PubMed Web of Science ®Google Scholar
• Green K., Symonds C. M., Elijah R. D., Zalkow L. H., Deutsch H. M., Bowman K. A., Morgan T. R. Water-soluble marihuana-derived material: Pharmacological actions in rabbit and primate. Curr. Eye Res. 1981; 1: 599/82
   Web of Science ®Google Scholar
• Kind L. S., Nilsson B. The biological activity of a ragweed arabinogalactan. 1. Galactose specificity of in vitro and in vivo effects. Immunology 1967; 13: 477
   PubMed Web of Science ®Google Scholar
• Baraldo W. T., Dias da Silva W., Lemos-Fernandez A. D. Inhibition effects of carbohydrates on histamine release and mast cell disruption by dextran. Br. J. Pharmacol. 1962; 19: 405
   Web of Science ®Google Scholar
• Green K., Cheeks K., Bowman K. A., Hodges L. C., Deutsch H. M., Zalkow L. H. Marihuana-derived material: Distribution and effects after systemic administration. Curr. Eye Res. 1984; 3: 751
   PubMed Web of Science ®Google Scholar
• Krupin T., Oestrich C. J., Bass J., Podos S. M., Becker B. Acidosis, alkalosis, and aqueous humor dynamics in rabbits. Invest. Ophthalmol. Vis. Sci. 1977; 16: 997
   PubMed Web of Science ®Google Scholar
• Marcus D. R., Krupin T., Podos S. M., Becker B. The effect of exercise on intraocular pressure: II. Rabbits. Invest. Ophthalmol. 1970; 9: 753
   PubMedGoogle Scholar
• Green K., Cheeks K., Mittag T., Riley M. V., Symonds C. M., Deutsch H. M., Hodges L. C., Zalkow L. H. Marihuana-derived material: Biochemical studies of the ocular responses. Curr. Eye Res. 1985; 4: 631
   PubMed Web of Science ®Google Scholar
• Green K., Cheeks K. E., Watkins L., Bowman K. A., McDonald T. F., Ocasio H., Deutsch H. M., Hodges L. C., Zalkow L. H. Prostaglandin involvement in the responses of the rabbit eye to water-soluble marihuana-derived material. Curr. Eye Res. 1987; 6: 337
   PubMed Web of Science ®Google Scholar
• Lee P., Podos S. M., Severin C. Effect of prostaglandin F2α on aqueous humor dynamics of rabbit, cat, and monkey. Invest. Ophthalmol. Vis. Sci. 1984; 25: 1087
   PubMed Web of Science ®Google Scholar
• Hodges L. C., Deutsch H. M., Green K., Zalkow L. H. Polysaccharides from Cannabis sativa active in lowering intraocular pressure. Carbohydrate Polymers 1985; 5: 141
   Web of Science ®Google Scholar
• Deutsch H. M., Green K., Zalkow L. H. Water-soluble high molecular weight components from plants with potent intraocular pressure lowering activity. Curr. Eye Res. 1987; 6: 949–950
   PubMed Web of Science ®Google Scholar
• McDonald T. F., Green K. Effects of water-soluble marihuana-derived material (MDM) on the rabbit ciliary body: Light and electron microscopy. Curr. Eye Res. 1986; 5: 457
   PubMed Web of Science ®Google Scholar
• Green K., Slagle T., Forbes E., McDonald T. F., Deutsch H. M., Zalkow L. H., Pharmacological and morphological responses of the rabbit eye to different routes of administration of water-soluble marihuana-derived material (in preparation).
   Google Scholar
• McDonald T. F., Cheeks L., Slagle T., Green K., Morphological and pharmacological effects of water-soluble marihuana-derived material in the monkey eye (in preparation).
   Google Scholar
• Gregory D., Sears M., Bausher L., Mishima H., Mead A. Intraocular pressure and aqueous flow are decreased by cholera toxin. Invest. Ophthalmol. Vis. Sci. 1981; 20: 371
   PubMed Web of Science ®Google Scholar
• Battels S. P., Roth H. O., Neufeld A. H. Effects of intravitreal cholera toxin on adenosine 3′, 5′-monophosphate, intraocular pressure, and outflow facility in rabbits. Invest. Ophthalmol. Vis. Sci. 1981; 20: 410
   PubMed Web of Science ®Google Scholar
• Drance S. M., Flammer J. Some effects of antiglaucoma drugs on visual function. Glaucoma: Applied Pharmacology in Medical Treatment, S. M. Drance, A. H. Neufeld. Grune & Stratum, Orlando 1984
   Google Scholar
• Bito L. Z., Draga A., Blanco J., Camras C. B. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical applications of prostaglandins to cat or rhesus monkey eyes. Invest. Ophthalmol. Vis. Sci. 1983; 24: 312
   PubMed Web of Science ®Google Scholar
• Camras C. B., Bhuyan K. C., Podos S. M., Bhuyan D. K., Master R. W. P. Multiple dosing of prostaglandin F2α or epinephrine on cynomolgus monkey eyes. n. Slit-lamp biomicroscopy, aqueous humor analysis, and fluorescein angiography. Invest. Ophthalmol. Vis. Sci. 1987; 28: 921
   PubMed Web of Science ®Google Scholar